<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1470-7330-14-S1-O20</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-O20</article-id><article-categories><subj-group subj-group-type="heading"><subject>Oral Presentation</subject></subj-group></article-categories><title-group><article-title>Locoregional therapy of renal cancer</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Wah</surname><given-names>Tze Min</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>Tze.Wah@leedsth.nhs.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Diagnostic and Interventional Radiology, Institute of Oncology, St. James' University Hospital, Leeds Teaching Hospitals Trust, Beckett Street, Leeds, LS9 7TF, UK</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>O20</fpage><lpage>O20</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Wah; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Wah; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/O20"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title/><p>This lecture aims to provide an overview of renal cell carcinoma (RCC) and insights into this rapidly evolving treatment &#x02013; image guided thermal ablative (IGA) therapy. RCC is the commonest kidney cancer and the detection of RCC has increased over the past decade. There are over 8000 and 50,000 new cases/year in the UK and USA respectively [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. The increased detection is due to wider usage of radiology (e.g. ultrasound or computed tomography) and this usually results in the detection of smaller RCC with earlier stage disease [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. In addition, this is also related to the rise in incidence in the general population as a result of smoking and obesity [<xref ref-type="bibr" rid="B5">5</xref>-<xref ref-type="bibr" rid="B7">7</xref>].</p><p>The historical classical clinical triad where patients presented with flank pain, abdominal mass and haematuria is now a rarity and nowadays the majority of the incidentally detected RCCs are smaller and at an earlier stage &#x02013;T1 stage. However, historical data has suggested that 60% of these small incidentally detected tumours will grow gradually over a period of time [<xref ref-type="bibr" rid="B8">8</xref>]. Therefore, there remains a clinical risk with adopting a &#x02018;watchful waiting&#x02019; approach for younger patients as these tumours may become symptomatic or metastasize [<xref ref-type="bibr" rid="B9">9</xref>].</p><p>Open radical nephrectomy (RN) was the gold standard treatment for RCC since it was introduced in 1869 and Robson et al had popularized this treatment over the last 50 years [<xref ref-type="bibr" rid="B10">10</xref>].Over the past 10 years, laparoscopic RN is becoming the standard of care with better cosmetic results and shorter recovery time [<xref ref-type="bibr" rid="B11">11</xref>]. More recently for locally confined (T1 disease) RCC treatment with nephron sparing surgery (NSS) e.g. open/ laparoscopic PN has demonstrated similar oncological durability to that of the gold standard RN [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>]. RN is now largely considered an overtreatment for T1a (&#x0003c;4cm) RCC because it is associated with greater nephron loss and earlier onset of chronic kidney disease and also associated with increased cardiovascular events after RN [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Therefore, the current consensus is that RCC at stage T1a (&#x0003c;4 cm), should be treated with minimally invasive techniques in order to preserve renal function. Nephron sparing surgery (NSS) with either laparoscopic/open PN is advised whenever it is deemed technically possible [<xref ref-type="bibr" rid="B16">16</xref>]. Although, the NSS has similar recurrence free and long term survival outcomes as those with RN, NSS remains technically challenging and associated with significant morbidity even in expert hands [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Given the surgical challenges and the quest to preserve renal function, IGA treatment of the smaller RCC with radiofrequency ablation (RFA), cryoablation (CRYO) and microwave (MWA) has evolved rapidly over the last decade. Today, IGA of RCC has proven to be a safe and effective treatment option and good oncological outcome data is emerging for RFA [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B22">22</xref>] and CRYO [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. In the hands of an experienced interventional oncologist, the primary technical success is now approaching &#x0003e;95% for both IGA with RFA and CRYO. As RFA was introduced earlier, the emerging larger RFA series have demonstrated cancer specific survival of 97-100% with a follow up of 61-78 months [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B22">22</xref>].</p></sec></body><back><sec><title>Acknowledgements</title><p>I would to acknowledge my interventional oncology (IO) team (radiologists-Dr Bobby Bhartia, Dr Jonathan Smith, Dr Simon Burbidge), anaesthetist (Dr Simon Whiteley) and lead ODA (David Brown), lead nurse (Bali Bhambra), lead radiographer (Mike Gallagher) and lead administrative coordinator (Janette Bambrook) and collaborative clinicians and allied healthcare staff at Leeds Teaching Hospital Trust as the success of this programme is very much as a result of effective team working.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="book"><collab>Statistics Of N</collab><source>Cancer Statistics registrations: Registrations of cancer diagnosed in 2008, England</source><year>2010</year><volume>MB1</volume><publisher-name>Office for National Statistics, National Statistics London</publisher-name></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Jemal</surname><given-names>A</given-names></name><name><surname>Siegel</surname><given-names>R</given-names></name><name><surname>Ward</surname><given-names>E</given-names></name><name><surname>Hao</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Thun</surname><given-names>MJ</given-names></name><article-title>Cancer statistics, 2009</article-title><source>CA Cancer J Clin</source><year>2009</year><volume>59</volume><issue>4</issue><fpage>225</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">19474385</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Patard</surname><given-names>JJ</given-names></name><name><surname>Rodriguez</surname><given-names>A</given-names></name><name><surname>Rioux-Leclercq</surname><given-names>N</given-names></name><name><surname>Guille</surname><given-names>F</given-names></name><name><surname>Lobel</surname><given-names>B</given-names></name><article-title>Prognostic significance of the mode of detection in renal tumours</article-title><source>BJU Int</source><year>2002</year><volume>90</volume><issue>4</issue><fpage>358</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">12175389</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Tsui</surname><given-names>KH</given-names></name><name><surname>Shvarts</surname><given-names>O</given-names></name><name><surname>Smith</surname><given-names>RB</given-names></name><name><surname>Figlin</surname><given-names>RA</given-names></name><name><surname>deKernion</surname><given-names>JB</given-names></name><name><surname>Belldegrun</surname><given-names>A</given-names></name><article-title>Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria</article-title><source>J Urol</source><year>2000</year><volume>163</volume><issue>4</issue><fpage>1090</fpage><lpage>1095</lpage><pub-id pub-id-type="pmid">10737472</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Jayson</surname><given-names>M</given-names></name><name><surname>Sanders</surname><given-names>H</given-names></name><article-title>Increased incidence of serendipitously discovered renal cell carcinoma</article-title><source>Urology</source><year>1998</year><volume>51</volume><issue>2</issue><fpage>203</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">9495698</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Hollingsworth</surname><given-names>JM</given-names></name><name><surname>Miller</surname><given-names>DC</given-names></name><name><surname>Daignault</surname><given-names>S</given-names></name><name><surname>Hollenbeck</surname><given-names>BK</given-names></name><article-title>Rising incidence of small renal masses: a need to reassess treatment effect</article-title><source>J Natl Cancer Inst</source><year>2006</year><volume>98</volume><issue>18</issue><fpage>1331</fpage><lpage>1334</lpage><pub-id pub-id-type="pmid">16985252</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Nguyen</surname><given-names>MM</given-names></name><name><surname>Gill</surname><given-names>IS</given-names></name><name><surname>Ellison</surname><given-names>LM</given-names></name><article-title>The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program</article-title><source>J Urol</source><year>2006</year><volume>176</volume><issue>6 Pt 1</issue><fpage>2397</fpage><lpage>2400</lpage><comment>discussion 2400</comment><pub-id pub-id-type="pmid">17085111</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Kato</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Terasawa</surname><given-names>Y</given-names></name><name><surname>Sasano</surname><given-names>H</given-names></name><name><surname>Arai</surname><given-names>Y</given-names></name><article-title>Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis</article-title><source>J Urol</source><year>2004</year><volume>172</volume><issue>3</issue><fpage>863</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">15310984</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Abouassaly</surname><given-names>R</given-names></name><name><surname>Lane</surname><given-names>BR</given-names></name><name><surname>Novick</surname><given-names>AC</given-names></name><article-title>Active surveillance of renal masses in elderly patients</article-title><source>J Urol</source><year>2008</year><volume>180</volume><issue>2</issue><fpage>505</fpage><lpage>508</lpage><comment>discussion 508-509</comment><pub-id pub-id-type="pmid">18550113</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Robson</surname><given-names>CJ</given-names></name><name><surname>Churchill</surname><given-names>BM</given-names></name><name><surname>Anderson</surname><given-names>W</given-names></name><article-title>The results of radical nephrectomy for renal cell carcinoma</article-title><source>J Urol</source><year>1969</year><volume>101</volume><issue>3</issue><fpage>297</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">5765875</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="other"><collab>NICE</collab><article-title>Guidance on Cancer Services. Improving Outcome in Urological Cancers</article-title><year>2002</year></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Hemal</surname><given-names>AK</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Kumar</surname><given-names>R</given-names></name><name><surname>Wadhwa</surname><given-names>P</given-names></name><name><surname>Seth</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>NP</given-names></name><article-title>Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison</article-title><source>J Urol</source><year>2007</year><volume>177</volume><issue>3</issue><fpage>862</fpage><lpage>866</lpage><pub-id pub-id-type="pmid">17296361</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Gill</surname><given-names>IS</given-names></name><name><surname>Kavoussi</surname><given-names>LR</given-names></name><name><surname>Lane</surname><given-names>BR</given-names></name><name><surname>Blute</surname><given-names>ML</given-names></name><name><surname>Babineau</surname><given-names>D</given-names></name><name><surname>Colombo</surname><given-names>JR</given-names><suffix>Jr.</suffix></name><name><surname>Frank</surname><given-names>I</given-names></name><name><surname>Permpongkosol</surname><given-names>S</given-names></name><name><surname>Weight</surname><given-names>CJ</given-names></name><name><surname>Kaouk</surname><given-names>JH</given-names></name><name><surname>Kattan</surname><given-names>MW</given-names></name><name><surname>Novick</surname><given-names>AC</given-names></name><article-title>Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors</article-title><source>J Urol</source><year>2007</year><volume>178</volume><issue>1</issue><fpage>41</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">17574056</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>WC</given-names></name><name><surname>Elkin</surname><given-names>EB</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Jang</surname><given-names>TL</given-names></name><name><surname>Russo</surname><given-names>P</given-names></name><article-title>Partial nephrectomy versus radical nephrectomy in patients with small renal tumors--is there a difference in mortality and cardiovascular outcomes?</article-title><source>J Urol</source><year>2009</year><volume>181</volume><issue>1</issue><fpage>55</fpage><lpage>61</lpage><comment>discussion 61-52</comment><pub-id pub-id-type="pmid">19012918</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>WC</given-names></name><name><surname>Levey</surname><given-names>AS</given-names></name><name><surname>Serio</surname><given-names>AM</given-names></name><name><surname>Snyder</surname><given-names>M</given-names></name><name><surname>Vickers</surname><given-names>AJ</given-names></name><name><surname>Raj</surname><given-names>GV</given-names></name><name><surname>Scardino</surname><given-names>PT</given-names></name><name><surname>Russo</surname><given-names>P</given-names></name><article-title>Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study</article-title><source>Lancet Oncol</source><year>2006</year><volume>7</volume><issue>9</issue><fpage>735</fpage><lpage>740</lpage><pub-id pub-id-type="pmid">16945768</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Ljungberg</surname><given-names>B</given-names></name><name><surname>Cowan</surname><given-names>NC</given-names></name><name><surname>Hanbury</surname><given-names>DC</given-names></name><name><surname>Hora</surname><given-names>M</given-names></name><name><surname>Kuczyk</surname><given-names>MA</given-names></name><name><surname>Merseburger</surname><given-names>AS</given-names></name><name><surname>Patard</surname><given-names>JJ</given-names></name><name><surname>Mulders</surname><given-names>PF</given-names></name><name><surname>Sinescu</surname><given-names>IC</given-names></name><article-title>EAU guidelines on renal cell carcinoma: the 2010 update</article-title><source>Eur Urol</source><year>2010</year><volume>58</volume><issue>3</issue><fpage>398</fpage><lpage>406</lpage><pub-id pub-id-type="pmid">20633979</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Levinson</surname><given-names>AW</given-names></name><name><surname>Su</surname><given-names>LM</given-names></name><name><surname>Agarwal</surname><given-names>D</given-names></name><name><surname>Sroka</surname><given-names>M</given-names></name><name><surname>Jarrett</surname><given-names>TW</given-names></name><name><surname>Kavoussi</surname><given-names>LR</given-names></name><name><surname>Solomon</surname><given-names>SB</given-names></name><article-title>Long-term oncological and overall outcomes of percutaneous radio frequency ablation in high risk surgical patients with a solitary small renal mass</article-title><source>J Urol</source><year>2008</year><volume>180</volume><issue>2</issue><fpage>499</fpage><lpage>504</lpage><comment>discussion 504</comment><pub-id pub-id-type="pmid">18550123</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Ferakis</surname><given-names>N</given-names></name><name><surname>Bouropoulos</surname><given-names>C</given-names></name><name><surname>Granitsas</surname><given-names>T</given-names></name><name><surname>Mylona</surname><given-names>S</given-names></name><name><surname>Poulias</surname><given-names>I</given-names></name><article-title>Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors</article-title><source>J Endourol</source><year>2010</year><volume>24</volume><issue>12</issue><fpage>1909</fpage><lpage>1913</lpage><pub-id pub-id-type="pmid">20946062</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Zagoria</surname><given-names>RJ</given-names></name><name><surname>Pettus</surname><given-names>JA</given-names></name><name><surname>Rogers</surname><given-names>M</given-names></name><name><surname>Werle</surname><given-names>DM</given-names></name><name><surname>Childs</surname><given-names>D</given-names></name><name><surname>Leyendecker</surname><given-names>JR</given-names></name><article-title>Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma</article-title><source>Urology</source><year>2011</year><volume>77</volume><issue>6</issue><fpage>1393</fpage><lpage>1397</lpage><pub-id pub-id-type="pmid">21492910</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Olweny</surname><given-names>EO</given-names></name><name><surname>Park</surname><given-names>SK</given-names></name><name><surname>Tan</surname><given-names>YK</given-names></name><name><surname>Best</surname><given-names>SL</given-names></name><name><surname>Trimmer</surname><given-names>C</given-names></name><name><surname>Cadeddu</surname><given-names>JA</given-names></name><article-title>Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up</article-title><source>Eur Urol</source><year>2012</year><volume>61</volume><issue>6</issue><fpage>1156</fpage><lpage>1161</lpage><pub-id pub-id-type="pmid">22257424</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Wah</surname><given-names>TM</given-names></name><name><surname>Irving</surname><given-names>HC</given-names></name><name><surname>Gregory</surname><given-names>W</given-names></name><name><surname>Cartledge</surname><given-names>J</given-names></name><name><surname>Joyce</surname><given-names>AD</given-names></name><name><surname>Selby</surname><given-names>PJ</given-names></name><article-title>Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours</article-title><source>BJU Int</source><year>2014</year><volume>113</volume><issue>3</issue><fpage>416</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">24053769</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Psutka</surname><given-names>SP</given-names></name><name><surname>Feldman</surname><given-names>AS</given-names></name><name><surname>McDougal</surname><given-names>WS</given-names></name><name><surname>McGovern</surname><given-names>FJ</given-names></name><name><surname>Mueller</surname><given-names>P</given-names></name><name><surname>Gervais</surname><given-names>DA</given-names></name><article-title>Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma</article-title><source>Eur Urol</source><year>2013</year><volume>63</volume><issue>3</issue><fpage>486</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">22959191</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Buy</surname><given-names>X</given-names></name><name><surname>Lang</surname><given-names>H</given-names></name><name><surname>Garnon</surname><given-names>J</given-names></name><name><surname>Sauleau</surname><given-names>E</given-names></name><name><surname>Roy</surname><given-names>C</given-names></name><name><surname>Gangi</surname><given-names>A</given-names></name><article-title>Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors</article-title><source>AJR Am J Roentgenol</source><year>2013</year><volume>201</volume><issue>6</issue><fpage>1353</fpage><lpage>1361</lpage><pub-id pub-id-type="pmid">24261377</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Breen</surname><given-names>DJ</given-names></name><name><surname>Bryant</surname><given-names>TJ</given-names></name><name><surname>Abbas</surname><given-names>A</given-names></name><name><surname>Shepherd</surname><given-names>B</given-names></name><name><surname>McGill</surname><given-names>N</given-names></name><name><surname>Anderson</surname><given-names>JA</given-names></name><name><surname>Lockyer</surname><given-names>RC</given-names></name><name><surname>Hayes</surname><given-names>MC</given-names></name><name><surname>George</surname><given-names>SL</given-names></name><article-title>Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients</article-title><source>BJU Int</source><year>2013</year><volume>112</volume><issue>6</issue><fpage>758</fpage><lpage>765</lpage><pub-id pub-id-type="pmid">23581293</pub-id></mixed-citation></ref></ref-list></back></article>
